Literature DB >> 10830781

Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis.

A Hartmann1, U Rösner, G Schlake, W Dietmaier, D Zaak, F Hofstaedter, R Knuechel.   

Abstract

Multifocality and recurrence are clinically important features of urothelial carcinomas of the urinary bladder. Recent molecular genetic studies have suggested that multifocal urothelial carcinomas are monoclonally derived from an identical transformed progenitor cell. However, most of these studies investigated advanced and poorly differentiated tumors. The study presented focuses on early papillary tumors, including 52 superficial well-differentiated multifocal and recurrent bladder carcinomas from 10 patients. Microdissection separating urothelium from stromal cells was considered essential to obtain pure tumor cell populations. Genetic analysis was carried out by applying two different methods. Dual color fluorescence in situ hybridization (FISH) with centromeric probes for chromosomes 9 and 17 and gene-specific probes for chromosome loci 9q22, 9p21, and 17p13 was carried out in parallel to loss of heterozygosity (LOH) analyses applying 5 microsatellite markers on these chromosomes. Overall, deletions on chromosome 9p were found in 47 tumors (90%), at chromosome 9q in 36 tumors (69%) and at chromosome 17p in 3 tumors (6%). There was a very high correlation of the results between FISH and LOH analysis. Ten early superficial papillary tumors showed deletion of chromosome 9p without deletion of 9q, suggesting 9p deletions as a very early event in the development of papillary urothelial carcinoma. Although in four patients, all investigated tumors showed identical genetic alterations and one patient showed no genetic alterations at the loci investigated, in five patients, two or more clones with different deletions were found. In four of these patients, the results are compatible with clonal divergence and selection of different cell subpopulations derived from a common progenitor cell. However, in one patient different alleles in two markers at chromosome 9 were deleted, favoring an independent evolution of two recurring tumor cell clones. In summary, we could show that there is considerable genetic heterogeneity in early multifocal and recurring urothelial carcinoma and demonstrated the occurrence of two independent clones in at least one patient as an indicator of possible initial oligoclonality of bladder cancer.

Entities:  

Mesh:

Year:  2000        PMID: 10830781     DOI: 10.1038/labinvest.3780074

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  21 in total

1.  Metanephric adenoma of the kidney: a clinicopathological and molecular study of two cases.

Authors:  Maximilian Burger; Kerstin Junker; Stefan Denzinger; Thomas Schubert; Robert Stoehr; Wolf-Ferdinand Wieland; Arndt Hartmann
Journal:  J Clin Pathol       Date:  2006-11-10       Impact factor: 3.411

2.  Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden.

Authors:  Laura Thomas; Lan Kluwe; Nadia Chuzhanova; Victor Mautner; Meena Upadhyaya
Journal:  Neurogenetics       Date:  2010-04-01       Impact factor: 2.660

3.  Spatial and temporal clonal evolution during development of metastatic urothelial carcinoma.

Authors:  Mathilde B H Thomsen; Iver Nordentoft; Philippe Lamy; Søren Høyer; Søren Vang; Jakob Hedegaard; Michael Borre; Jørgen B Jensen; Torben F Ørntoft; Lars Dyrskjøt
Journal:  Mol Oncol       Date:  2016-08-17       Impact factor: 6.603

4.  Non-invasive papillary urothelial carcinoma of the vagina: molecular analysis of a rare case identifies clonal relationship to non-invasive urothelial carcinoma of the bladder.

Authors:  Hind N Warzecha; Falko Fend; Julia Steinhilber; Harald Abele; Melanie Henes; Niklas Harland; Annette Staebler
Journal:  Virchows Arch       Date:  2017-06-07       Impact factor: 4.064

5.  Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings.

Authors:  Gill Spurlock; Samantha J L Knight; Nick Thomas; Tim-Rasmus Kiehl; Abhijit Guha; Meena Upadhyaya
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-15       Impact factor: 4.553

6.  Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer.

Authors:  F Bataille; P Rümmele; W Dietmaier; D Gaag; F Klebl; A Reichle; P Wild; F Hofstädter; A Hartmann
Journal:  Mol Pathol       Date:  2003-10

Review 7.  Tissue engineering for the oncologic urinary bladder.

Authors:  Tomasz Drewa; Jan Adamowicz; Arun Sharma
Journal:  Nat Rev Urol       Date:  2012-08-21       Impact factor: 14.432

8.  Biomarkers in bladder cancer: present status and perspectives.

Authors:  Wun-Jae Kim; Soongang Park; Yong-June Kim
Journal:  Biomark Insights       Date:  2007-03-27

9.  [Precancerous conditions in the urothelium. Early detection and molecular understanding through endoscopic fluorescence diagnosis].

Authors:  R Knüchel; A Hartmann; R Stöhr; R Baumgartner; D Zaak; R C Krieg
Journal:  Pathologe       Date:  2003-10       Impact factor: 1.011

10.  A tumour with a neuroendocrine and papillary serous component: two or a pair?

Authors:  S Van Eeden; P M Nederlof; B G Taal; G J A Offerhaus; M-L F Van Velthuysen
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.